BostonGene raises $50M series A to develop personalized cancer therapy software

BostonGene will deploy its $50 million series A funds to scale and develop its cloud-based platform for determining optimal patient-specific cancer therapies.

NEC Corp. is the sole investor in the untranched financing announced on Wednesday. ...